NEWS
SUBSCRIBER SEARCH (Requires Login)
  NEW DRUGS
  MARKETED DRUGS
  COMPANY
  TARGETS IN ONCOLOGY
  NEWS SUMMARIES
  COMBINATION TRIALS

Latest Updates

November 2009 New Drug Updates and Additions

Designation

Brand Name

Generic Name

ADC-1009

 

 

ARQ-650RP, ARQ 650RP, ARQ 197, ARQ197

   

AT-101

 

 

AT13387

 

 

ZD6474, AZD6474, AZD-6474

Zactima

Vandetanib

ZD4054, AZD4054, ZD1611

 

Zibotentan

AZD6244, ARRY-142886, ARRY-886

 

 

BLX-883

Locteron

 

CEQ501

 

 

CGX-635, NSC-141633

Omapro (formerly Ceflatonin)

Omacetaxine mepesuccinate

 

 

Salirasib

DOXO-EMCH, INNO-206

 

 

Antigen-presenting cells 8015 (APC8015)

Provenge

Sipuleucel-T

EZN-3920

 

 

GLPG0187

 

 

 

TNFerade

 

GTx-758

 

 

rHuPH20

Chemophase

Hyaluronidase

HBI-8000, CS055

 

Chidamide

INCB7839, INCB007839

 

 

INCB18424

 

 

JX-594

 

 

NV1020

 

 

MBT-0206, EndoT-1

EndoTAG-1

Paclitaxel

MDVN 300 series, MDV3100

 

 

MK-1775

 

 

MLN4924

 

 

miR-Rx34

 

 

MPC-2130 (formerly MPI-176716)

 

 

MPC-6827, MPC6827

Azixa

 

MPC-3100

 

 

MPI-0485520 and related IKKE inhibitors

 

 

INCB28060

 

 

NOX-A50

Spiegelmer

 

AVR118, AVR 118, OHR118

Formerly Product R or Reticulose

 

Reolysin (formerly Reosyn)

 

 

PEP005 Topical

 

Ingenol mebutate

VEGF Trap, VEGF-Trap, AVE0005, NSC 724770

 

Aflibercept

Anti-PlGF, TB-403, TH403

 

 

XRP9881, XRP9881A, 109,881 (formerly RPR 109881A, RPR109881, 109881)

 

Larotaxel

XL147, SAR245408

 

 

XL765

 

 

SPC2996

 

 

SPC2968, EZN2968, EZN-2968

 

 

eIF5A1, eIF-5A, factor 5A1 (F5A1), factor 5A

 

 

EO9

EOquin, Neoquin

Apaziquone

SNS-595, SPC-595 (formerly AG-7352)

 

Voreloxin

TH-302, HAP-302

 

 

  

Home   |    Freelance Opportunities   |   New Medicine   |   Site Map   |  Order/Inquiry   
SUBSCRIBER SEARCH:   NEW DRUG   |   MARKETED DRUG   |   COMPANY   |   TARGETS IN ONCOLOGY  

NEW MEDICINE, INC.
P.O. BOX 909, LAKE FOREST, CA 92609
PHONE:  1-949-830-0448     FAX:  1-949-830-0887
INFO@NEWMEDINC.COM